Glenmede Trust CO Na Charles River Laboratories International, Inc. Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 1,210 shares of CRL stock, worth $238,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,210

Previous 1,105 9.5%

Holding current value

$238,249

Previous $228,000 4.39%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $19,735 - $25,755	105 Added 9.5%	1,210 $238,000
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $3,715 - $4,837	18 Added 1.66%	1,105 $228,000
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $9,972 - $13,398	49 Added 4.72%	1,087 $294,000
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $170,771 - $247,915	1,038 New	1,038 $245,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $188,437 - $239,066	956 New	956 $208,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $169,632 - $251,294	-831 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $12,264 - $17,381	48 Added 6.13%	831 $235,000
Q4 2021 Feb 15, 2022	SELL	$351.38 - $448.68 $179,555 - $229,275	-511 Reduced 39.49%	783 $294,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $8,198 - $10,082	22 Added 1.73%	1,294 $532,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $129,728 - $163,897	441 Added 53.07%	1,272 $470,000
Q1 2021 May 18, 2021	SELL	$249.67 - $299.48 $26,714 - $32,044	-107 Reduced 11.41%	831 $240,000
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $3,552 - $4,041	-16 Reduced 1.68%	938 $233,000
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $24,753 - $31,929	-141 Reduced 12.88%	954 $215,000
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $13,191 - $21,058	-111 Reduced 9.2%	1,095 $190,000
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $119,999 - $145,427	952 Added 374.8%	1,206 $184,000
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $23,137 - $26,578	-185 Reduced 42.14%	254 $33,000
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $22,212 - $26,739	-180 Reduced 29.08%	439 $62,000
Q1 2019 May 14, 2019	BUY	$104.82 - $146.73 $18,867 - $26,411	180 Added 41.0%	619 $89,000
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $1.42 Million - $1.85 Million	-13,517 Reduced 96.85%	439 $48,000
Q3 2018 Nov 15, 2018	SELL	$112.11 - $134.54 $2.35 Million - $2.82 Million	-20,995 Reduced 60.07%	13,956 $1.88 Million
Q4 2017 Feb 15, 2018	SELL	$100.43 - $118.09 $1,707 - $2,007	-17 Reduced 0.05%	34,951 $3.82 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $3.38 Million - $3.82 Million	34,968	34,968 $0

Others Institutions Holding CRL

# of Institutions

691

Shares Held

52.3M

Call Options Held

226K

Put Options Held

410K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Charles River Laboratories International, Inc. Transaction History